Effect of estrogen on the pain of uterine cervical dilatation in rats

LI Wenhui,YAN Tao,AN Guanghui,LI Shitong,WANG Zhengping
2013-01-01
Abstract:Objective To explore the fast effect and mechanism of estrogen on the pain of uterine cervical dilatation (UCD) in rats. Methods UCD models were established in 40 female rats 14 to 20 days after ovariectomization. The rats were given 100 ng 17-β estrogen (E2 group), 300 ng G protein-coupled the estrogen receptor (GPR30) agonist G-1 (G-1group), 1 000 ng GPR30 antagonist G-15 plus 100 ng estrogen (G-15 group), or PBS solution including 0.1 dimethyl sulfoxide (control group) by caudal vein. The total volume of drugs in the four groups was 1 mL. Electromyogram changes of rectus abdominis were compared 30 mins before and after intravenous injection. Results Eight rats were excluded because there were no correlation between the UCD and myoelectricity reaction. Finally there were 8 rats in each group. Finally there were no significant diffenrecs in the rat weights among groups before ovariectomization and UCD modeling (all P>0.05). With the increasing of the UCD force, electromyogram (EMG) response of rectus abdominis increased gradually. EMG responses of rectus abdominis on the 20, 40, 60, and 80 g UCD force in the E2 group and G-1 group were significantly increased as compared with control group (all P<0.05). There was no significant difference in EMG response under the same forces between G-15 group and control group (all P>0.05). Conclusion Intravenous injection of estrogen can increase rectus abdominis EMG response to UCD quickly in ovariectomized rats. GPR30 agonist can enhance the effect, and GPR30 antagonist can suppress the effect. The short term effect of estrogen on UCD pain may be mediated by GPR30 receptor pathway.
What problem does this paper attempt to address?